As a Senior Research Fellow, Andrew Dalton (BEcon, DipEd, GradDipHealthEcon&Eval, MEcon) has coordinated externally funded clinical trials and supervises a number of post-graduate students. He has extensive consulting experience in health economics for the State and Federal Governments, as well regular assignments for the World Bank and WHO. Although Andrew has strong interests in health sector priority setting, much of his work has been in economic evaluation, including the preparation of economic components of submissions to the Pharmaceutical Benefits Advisory Committee, for listing on the Pharmaceutical Benefits Scheme.
For more information including Andrew's qualifications, publications, research grants and classifications, visit
Find an Expert.